Novocuff Raises $26M to Improve Pregnancy Outcomes

Novocuff raises $26M in Series A Funding

Novocuff (Linkedin), a leading medical equipment manufacturer, recently secured $26M in Series A funding to advance their mission of improving pregnancy outcomes and reducing preterm births caused by PPROM and cervical shortening.

Funding Amount: $26 million

Industry: Medical Equipment Manufacturing

Employee Count: 2-10

CEO: Amelia Degenkolb (CEO Linkedin)

What Novocuff needs to buy: Novocuff is seeking collaborations with research institutions, healthcare providers, and marketing agencies to support their clinical trials, navigate regulatory requirements, and effectively reach healthcare professionals and organizations in the maternal health field. Companies specializing in clinical trial support, regulatory compliance services, and marketing expertise are ideal partners for Novocuff's expansion and impact in the medical industry.